Welcome to the HBVdb home page !

Service interruption between July 25 17h00 Paris time and July 26 12h00 Paris time.

The specialized Hepatitis B Virus (HBV) database, HBVdb, allows the researchers to investigate the genetic variability of the virus and the viral resistance to treatment. HBV is a major health problem worldwide with more than 350 million individuals being chronically infected. The main drugs used to treat infected patients are nucleos(t)ides analogs (reverse transcriptase inhibitors). Unfortunately, HBV mutants resistant to these drugs may be selected and be responsible for treatment failure. HBVdb contains a collection of computer-annotated sequences based on manually annotated reference genomes. The database web interface allows static and dynamic queries and provides integrated analysis tools including sequence annotation, genotyping and drug resistance profiling.

The current HBVdb release is 60.0 with 108683 entries and was last updated on 2024-04-10 (see news).

The HBVdb service has been accessed 323411 times by 38348 unique users since 2012 (see statistics).

If you use HBVdb in your work, please cite Hayer J. et al., Nucleic Acids Research, 2013 (see about).

Please use the menu bar above or the submit buttons below in order to access the Hepatitis B Virus Database (HBVdb) resources. A brief description of each resource will appear when the pointing device pauses over a menu or a button. You can find more explanations about how to use these resources in the help page from the HBVdb menu (see help).

© 1998-2024Centre National de la Recherche Scientifique logoInstitut national de la sante et de la recherche médicale logoUniversité de Lyon logoLegal notice